266 related articles for article (PubMed ID: 17351625)
21. Distribution of enzyme-bearing cells in GM2 gangliosidosis mice: regionally specific pattern of cellular infiltration following bone marrow transplantation.
Oya Y; Proia RL; Norflus F; Tifft CJ; Langaman C; Suzuki K
Acta Neuropathol; 2000 Feb; 99(2):161-8. PubMed ID: 10672323
[TBL] [Abstract][Full Text] [Related]
22. Conditional expression of human β-hexosaminidase in the neurons of Sandhoff disease rescues mice from neurodegeneration but not neuroinflammation.
Kyrkanides S; Brouxhon SM; Tallents RH; Miller JN; Olschowka JA; O'Banion MK
J Neuroinflammation; 2012 Aug; 9():186. PubMed ID: 22863301
[TBL] [Abstract][Full Text] [Related]
23. Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
Tsuji D; Kuroki A; Ishibashi Y; Itakura T; Kuwahara J; Yamanaka S; Itoh K
J Neurochem; 2005 Mar; 92(6):1497-507. PubMed ID: 15748167
[TBL] [Abstract][Full Text] [Related]
24. Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol.
Bourgoin C; Emiliani C; Kremer EJ; Gelot A; Tancini B; Gravel RA; Drugan C; Orlacchio A; Poenaru L; Caillaud C
Gene Ther; 2003 Oct; 10(21):1841-9. PubMed ID: 12960974
[TBL] [Abstract][Full Text] [Related]
25. Pronounced Therapeutic Benefit of a Single Bidirectional AAV Vector Administered Systemically in Sandhoff Mice.
Lahey HG; Webber CJ; Golebiowski D; Izzo CM; Horn E; Taghian T; Rodriguez P; Batista AR; Ellis LE; Hwang M; Martin DR; Gray-Edwards H; Sena-Esteves M
Mol Ther; 2020 Oct; 28(10):2150-2160. PubMed ID: 32592687
[TBL] [Abstract][Full Text] [Related]
26. Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes.
Flax JD; Aurora S; Yang C; Simonin C; Wills AM; Billinghurst LL; Jendoubi M; Sidman RL; Wolfe JH; Kim SU; Snyder EY
Nat Biotechnol; 1998 Nov; 16(11):1033-9. PubMed ID: 9831031
[TBL] [Abstract][Full Text] [Related]
27. Cerebral organoids derived from Sandhoff disease-induced pluripotent stem cells exhibit impaired neurodifferentiation.
Allende ML; Cook EK; Larman BC; Nugent A; Brady JM; Golebiowski D; Sena-Esteves M; Tifft CJ; Proia RL
J Lipid Res; 2018 Mar; 59(3):550-563. PubMed ID: 29358305
[TBL] [Abstract][Full Text] [Related]
28. Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice.
Wu YP; Proia RL
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8425-30. PubMed ID: 15155903
[TBL] [Abstract][Full Text] [Related]
29. Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice.
Itakura T; Kuroki A; Ishibashi Y; Tsuji D; Kawashita E; Higashine Y; Sakuraba H; Yamanaka S; Itoh K
Biol Pharm Bull; 2006 Aug; 29(8):1564-9. PubMed ID: 16880605
[TBL] [Abstract][Full Text] [Related]
30. Abnormal organization during neurodevelopment in a mouse model of Sandhoff disease.
Ogawa Y; Sasanuma Y; Shitara S; Koshizuka A; Okada R; Sakuraba H; Oishi K
Neurosci Res; 2020 Jun; 155():12-19. PubMed ID: 31340161
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
32. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
[TBL] [Abstract][Full Text] [Related]
33. Neurological and cardiac responses after treatment with miglustat and a ketogenic diet in a patient with Sandhoff disease.
Villamizar-Schiller IT; Pabón LA; Hufnagel SB; Serrano NC; Karl G; Jefferies JL; Hopkin RJ; Prada CE
Eur J Med Genet; 2015 Mar; 58(3):180-3. PubMed ID: 25497207
[TBL] [Abstract][Full Text] [Related]
34. Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease.
Buccoliero R; Bodennec J; Van Echten-Deckert G; Sandhoff K; Futerman AH
J Neurochem; 2004 Jul; 90(1):80-8. PubMed ID: 15198669
[TBL] [Abstract][Full Text] [Related]
35. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
Phaneuf D; Wakamatsu N; Huang JQ; Borowski A; Peterson AC; Fortunato SR; Ritter G; Igdoura SA; Morales CR; Benoit G; Akerman BR; Leclerc D; Hanai N; Marth JD; Trasler JM; Gravel RA
Hum Mol Genet; 1996 Jan; 5(1):1-14. PubMed ID: 8789434
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy.
Bradbury AM; Cochran JN; McCurdy VJ; Johnson AK; Brunson BL; Gray-Edwards H; Leroy SG; Hwang M; Randle AN; Jackson LS; Morrison NE; Baek RC; Seyfried TN; Cheng SH; Cox NR; Baker HJ; Cachón-González MB; Cox TM; Sena-Esteves M; Martin DR
Mol Ther; 2013 Jul; 21(7):1306-15. PubMed ID: 23689599
[TBL] [Abstract][Full Text] [Related]
37. Bicistronic lentiviral vector corrects beta-hexosaminidase deficiency in transduced and cross-corrected human Sandhoff fibroblasts.
Arfi A; Bourgoin C; Basso L; Emiliani C; Tancini B; Chigorno V; Li YT; Orlacchio A; Poenaru L; Sonnino S; Caillaud C
Neurobiol Dis; 2005 Nov; 20(2):583-93. PubMed ID: 15953731
[TBL] [Abstract][Full Text] [Related]
38. Abnormal differentiation of Sandhoff disease model mouse-derived multipotent stem cells toward a neural lineage.
Ogawa Y; Kaizu K; Yanagi Y; Takada S; Sakuraba H; Oishi K
PLoS One; 2017; 12(6):e0178978. PubMed ID: 28575132
[TBL] [Abstract][Full Text] [Related]
39. Introduction of an N-glycan sequon into HEXA enhances human beta-hexosaminidase cellular uptake in a model of Sandhoff disease.
Matsuoka K; Tsuji D; Aikawa S; Matsuzawa F; Sakuraba H; Itoh K
Mol Ther; 2010 Aug; 18(8):1519-26. PubMed ID: 20571546
[TBL] [Abstract][Full Text] [Related]
40. Widespread correction of central nervous system disease after intracranial gene therapy in a feline model of Sandhoff disease.
McCurdy VJ; Rockwell HE; Arthur JR; Bradbury AM; Johnson AK; Randle AN; Brunson BL; Hwang M; Gray-Edwards HL; Morrison NE; Johnson JA; Baker HJ; Cox NR; Seyfried TN; Sena-Esteves M; Martin DR
Gene Ther; 2015 Feb; 22(2):181-9. PubMed ID: 25474439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
